Collaboration opportunities for ELISA based immunodiagnostics

We welcome collaborative opportunities for ELISA based immunodiagnostics with laboratories interested in expanding their clinical testing.

Gotham Biotech has developed strong collaborative associations with ARUP Laboratories and the Mayo Clinic in an effort to evaluate a new ELISA for Detection of Blastomyces dermatitidis antigen in urine.

Additionally, we have also worked closely with the Bay Area Lyme Research Foundation in Portola Valley, California in developing our Lyme Disease test.

Gotham Biotech is actively seeking collaborative opportunities with central reference laboratories interested in expanding their clinical testing portfolio as well as contract research opportunities. We have expertise in all immunodiagnostic assay formats across medical, veterinary and environmental applications.

Experienced team

Our scientific team has over 30 years of academic and industrial experience in the development of several immunodiagnostic formats. Particularly across medical, veterinary and environmental applications. We have extensive expertise in the field of rapid assay for the detection of human respiratory pathogens.

We are working on promising preliminary research for the direct detection of Lyme Disease and associated Borrelia burgdorferi urinary antigen. Additionally, we have expertise in developing rapid assay diagnostics including lateral flow immunodiagnostic systems.

Our facilities

Our laboratories have the facilities to develop ELISA based immunodiagnostics and rapid lateral flow immunodiagnostic platforms. We have the resources to support collaborative efforts and contract research with other entities.

We are continually seeking collaborative opportunities for ELISA based immunodiagnostics.

Our laboratories have the the facilities to develop ELISA based immunodiagnostics and rapid lateral flow immunodiagnostic platforms